Filing Details

Accession Number:
0001213900-15-007402
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-30 19:21:51
Reporting Period:
2015-09-28
Filing Date:
2015-09-30
Accepted Time:
2015-09-30 19:21:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1402479 Myos Corp MYOS Pharmaceutical Preparations (2834) 208758875
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398815 J Robert Hariri C/O Myos Corporation
45 Horsehill Road, Suite 106
Cedar Knolls NJ 07927
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-28 800 $2.65 90,864 No 4 P Direct
Common Stock Acquisiton 2015-09-29 1,500 $2.70 92,364 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the weighted average purchase price. Shares were acquired in multiple transactions at prices ranging from $2.60 per share to $2.66 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote
  2. Represents the weighted average purchase price. Shares were acquired in multiple transactions at prices ranging from $2.60 per share to $2.75 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.